Should additional value elements be included in cost-effectiveness analysis in pharmacoeconomic evaluation: a novel commentary
Abstract In recent years, international academics recognized that quality-adjusted life-years (QALYs) may not always fully capture the benefits produced by an intervention, and considered incorporating additional elements of value into cost-effectiveness analysis (CEA). Examples of these elements ar...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-10-01
|
| Series: | Cost Effectiveness and Resource Allocation |
| Online Access: | https://doi.org/10.1186/s12962-023-00490-4 |